Grant: Discovery Grants Program - Individual
University of Toronto
$22,000.00
A novel method for high-throughput, high level production of recombinant proteins in stably transfected mammalian cells without the need to screen colonies
EF 2008-09
Résumé
With the availability of the human and mouse genome sequences and a nearly completed identification of genes, we are now facing the next challenge; the functional annotation of the gene products, the proteins. To achieve a deeper understanding of our biology, and for more efficient interventions with disease processes, there is an ever-increasing demand for production of proteins in large quantities. This is usually done by the use of transgenic bacterial or mammalian cells. In order to ensure proper processing of mammalian proteins, the latter is preferred. Transgene expression in mammalian cell lines however is subject to huge variations in terms of the level and reliability of protein production. Thus, the current methodologies require screening of large numbers of transgenic cell lines (established to produce the same protein) for an optimal genomic insertion site of the transgene so that this providing the highest and most efficient and reliable production can be found. This selection process is cumbersome and requires high investments of time, labor and monetary resources.
) We have developed a means of total control of transgene insertion into a defined genomic site (docking site) in mouse Embryonic Stem cells, and this system has now successfully passed the proof-of-principle stage. Here we propose to translate this technology to protein producing cell lines and to identify sub-lines with optimum docking sites. This would in turn alleviate the burden of those screening processes needed with the methods used currently. Such an improvement is expected to have unprecedented impact on proteomics research and protein based drug manufacturing.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
355792-2008
Name nom
Nagy, Andras
Department département
Molecular Genetics
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
22000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
33
Committee name en
Molec. & Develop. Genetics
Committee name fr
Gén. moléculaire et dévelop.
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Protein manipulation and expression
Research subject fr
Expression et recombinaison protéiques
Partie
1
Nb partie
3
Application title
A novel method for high-throughput, high level production of recombinant proteins in stably transfected mammalian cells without the need to screen colonies
Keyword
NA
Application summary
With the availability of the human and mouse genome sequences and a nearly completed identification of genes, we are now facing the next challenge; the functional annotation of the gene products, the proteins. To achieve a deeper understanding of our biology, and for more efficient interventions with disease processes, there is an ever-increasing demand for production of proteins in large quantities. This is usually done by the use of transgenic bacterial or mammalian cells. In order to ensure proper processing of mammalian proteins, the latter is preferred. Transgene expression in mammalian cell lines however is subject to huge variations in terms of the level and reliability of protein production. Thus, the current methodologies require screening of large numbers of transgenic cell lines (established to produce the same protein) for an optimal genomic insertion site of the transgene so that this providing the highest and most efficient and reliable production can be found. This selection process is cumbersome and requires high investments of time, labor and monetary resources.
) We have developed a means of total control of transgene insertion into a defined genomic site (docking site) in mouse Embryonic Stem cells, and this system has now successfully passed the proof-of-principle stage. Here we propose to translate this technology to protein producing cell lines and to identify sub-lines with optimum docking sites. This would in turn alleviate the burden of those screening processes needed with the methods used currently. Such an improvement is expected to have unprecedented impact on proteomics research and protein based drug manufacturing.